Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer.

导出 OA

翻译打印收藏纠错

第一作者： Mariana,Chavez-MacGregor

第一单位： The University of Texas MD Anderson Cancer Center, Houston, TX.

作者： Mariana,Chavez-MacGregor ^[1] ; Jieling,Miao ^[2] ; Lajos,Pusztai ^[3] ; Matthew P,Goetz ^[4] ; Priya,Rastogi ^[5] ; Patricia A,Ganz ^[6] ; Eleftherios P,Mamounas ^[7] ; Soonmyung,Paik ^[8] ; Hanna,Bandos ^[9] ; Wajeeha,Razaq ^[10] ; Anne,O'Dea ^[11] ; Virginia,Kaklamani ^[12] ; Andrea L M,Silber ^[3] ; Lisa E,Flaum ^[13] ; Eleni,Andreopoulou ^[14] ; Albert G,Wendt ^[15] ; Jennifer F,Carney ^[16] ; Priyanka,Sharma ^[11] ; Julie R,Gralow ^[17] ; Danika L,Lew ^[2] ; William E,Barlow ^[2] ; Gabriel N,Hortobagyi ^[1]

作者单位： The University of Texas MD Anderson Cancer Center, Houston, TX. ^[1] SWOG Statistical Center, Seattle, WA. ^[2] Yale University Cancer Center, New Haven, CT. ^[3] Alliance, Mayo Clinic Comprehensive Cancer Center, Rochester, MN. ^[4] NRG Oncology, University of Pittsburgh, Pittsburgh, PA. ^[5] NRG Oncology, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA. ^[6] NRG Oncology, Orlando Health Cancer Institute, Orlando, FL. ^[7] Division of Pathology, NRG Oncology, Pittsburgh, PA. ^[8] NRG Oncology, NRG Oncology SDMC, University of Pittsburgh, Pittsburgh, PA. ^[9] University of Oklahoma, Oklahoma City, OK. ^[10] University of Kansas Medical Center, Westwood, KS. ^[11] University of Texas Health Sciences Center, San Antonio, TX. ^[12] Northwestern University, Chicago, IL. ^[13] New York Presbyterian/Weill Cornell Medical Center, New York, NY. ^[14] Dignity Health Cancer Center at Saint Joseph's Hospital and Medical Center, Phoenix, AZ. ^[15] Kaiser Permanente NCORP, Moanalua Medical Center, Honolulu, HI. ^[16] American Society of Clinical Oncology, Office of the Chief Medical Officer, Alexandria, VA. ^[17]